Home › Depression › Washington › Everett
Depression clinical trials in Everett, WA
5 studies for Depression are looking for participants at sites in and around Everett (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RecruitingPhase 3
- Core Clinical Research, Everett
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
RecruitingPhase 2
- Seaport Investigator Site, Everett
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RecruitingPhase 3
- Core Clinical Research /ID# 226374, Everett
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 3
- Neurocrine Clinical Site, Everett
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
RecruitingPhase 4
- Clinical Research Site, Everett
About Depression
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
More about Depression on MedlinePlus
Depression trials in other cities
- Boston, MA50 studies
- New York City, NY44 studies
- Chicago, IL26 studies
- Atlanta, GA22 studies
- Pittsburgh, PA22 studies
- Philadelphia, PA21 studies
- Charleston, SC18 studies
- San Diego, CA18 studies
- Houston, TX18 studies
- Los Angeles, CA17 studies
- Washington, DC16 studies
- San Francisco, CA15 studies
Other studies in Everett
- Major Depressive Disorder7 studies
- Breast Cancer6 studies
- Colorectal Cancer5 studies
- Schizophrenia4 studies
- Prostate Cancer4 studies
- Ovarian Cancer3 studies
- Bipolar Disorder3 studies
- Melanoma3 studies
- Attention Deficit Hyperactivity Disorder3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.